Tech & Health

Monday’s ICD-10 Provider Fair offered an update on some of the changes scheduled to occur later this year as Vanderbilt University Medical Center shifts to ICD-10, a new medical coding and reporting system that will add more specificity to tracking medical diagnoses.

At her recent Flexner Discovery Lecture, Suzanne Bakken, Ph.D., R.N., the Alumni Professor of Nursing and Biomedical Informatics at Columbia University, shares a laugh with Vanderbilt’s William Stead, M.D., left, and Kevin Johnson, M.D., M.S.

With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have any hidden therapeutic benefits that could warrant putting additional indications on the label and increasing production.

An international research group led by Vanderbilt University scientists has shown for the first time that a lipid, or fat molecule, can regulate “psychostimulant” behaviors by interacting with a brain protein.

Russ Altman, M.D., Ph.D., professor of Bioengineering, Genetics and Medicine at Stanford University, posed an intriguing question at last week’s Discovery Lecture: is it possible to predict drug side effects from the 3D-structure of proteins?

Vanderbilt University researchers and their Belgian colleagues have discovered the mechanism behind a multidrug transporter. Their findings, posted this week by Nature Chemical Biology, could lead to new treatments for multidrug resistant bacterial infections.

Linda Norman, DSN, R.N., who for 22 years has spearheaded curricular innovations at Vanderbilt University School of Nursing (VUSN), will become the school’s new dean pending Board of Trust approval, effective July 1.